Alnylam Pharmaceuticals
ALNY
#815
Rank
$30.19 B
Marketcap
$225.66
Share price
0.25%
Change (1 day)
-52.39%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company